Market Overview

Piper Jaffray Initiates Coverage on Orexigen Therapeutics, Inc. at Overweight, Announces $10.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for OREX

DateFirmActionFromTo
Dec 2015WallachBethDowngradesBuyHold
Dec 2015Bank of AmericaInitiates Coverage onUnderperform
Dec 2015Wells FargoDowngradesOutperformMarket Perform

View More Analyst Ratings for OREX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (OREX)

Get Benzinga's Newsletters